Patient Resources

About Type 2 Diabetes

Type 2 diabetes is a chronic condition characterized by elevated blood sugar levels. It typically arises when the body either does not produce enough insulin or when the insulin it makes is not used effectively (insulin resistance). In response, the pancreas initially compensates by producing extra insulin. However, over time, the pancreas may fail to produce sufficient insulin to keep blood glucose levels within a normal range. 

Although type 2 diabetes is more common among middle-aged and older adults, it is becoming increasingly prevalent among younger individuals due to factors such as poor diet, lack of physical activity, and rising obesity rates. 

Symptoms 

Risk factors 

Complications 

Prevention and Management

References

Overview of Liraglutide Biocon

Liraglutide Biocon is a once-daily, non-insulin injectable medication specifically formulated for Type 2 Diabetes Mellitus management in adults, adolescents, and children aged 10 years and older. Its unique GLP-1 receptor agonist action helps control blood sugar levels effectively and may also lower the risk of cardiovascular events in adults.

Benefits of Liraglutide Biocon

Improved Glycemic Control

 Effective in reducing both blood glucose levels and HbA1c in patients aged 10 years and older.

Reduced Cardiovascular Risks

Reduces cardiovascular morbidity and mortality in adults with Type 2 diabetes.

Flexible Therapy Options

Usable as a monotherapy or in combination with other diabetes medications for sustained glucose control.

How Liraglutide Biocon Works

Liraglutide Biocon activates GLP-1 receptors to help regulate glucose levels through:

Insulin Secretion Stimulation

Enhances glucose-dependent insulin release when blood sugar is high.

Reduced Glucagon Secretion

Lowers glucagon levels, thus controlling excessive glucose production.

Minor Delay in Gastric Emptying

Reduces hunger and helps in weight management.

This comprehensive mechanism helps control blood sugar without risking low blood sugar episodes during hypoglycemia.

Steps for administration

Formulation

Pre-filled device, containing 3 ml solution for 30 doses (0.6 mg), 15 doses (1.2 mg), or 10 doses (1.8 mg)

Dosage Guidance

Injection Instructions

 
1

Check the Device

Ensure the device is labeled correctly and the solution is clear.

2

Select Injection Area

Common sites include the abdomen, thigh, or upper arm.

3

Attach Needle

Use a new needle for each injection and follow provided instructions.

4

Inject Correct Dosage

Monitor the dose counter, keeping the needle under the skin for at least 6 seconds.

5

Dispose Safely

Dispose of the used needle securely and replace the device cap.

Note: Liraglutide Biocon requires BD Ultra-Fine® or NovoFine® disposable needles (32 G, up to 8 mm in length), which are not included with the device.

Storage Instructions

Side Effects and What to Expect

While Liraglutide Biocon is generally well-tolerated, some patients may experience side effects. Here’s a breakdown of common and serious reactions:

Note: Regularly monitor your condition, especially if using additional diabetes medications like sulfonylureas or insulin, which may increase the risk of hypoglycemia.

Tips for Reducing Injection Site Reactions

Contact and Support Resources

If you experience side effects or have questions about Liraglutide Biocon:

Proactively managing side effects and staying informed about the proper use of Liraglutide Biocon can enhance your treatment experience and support better outcomes.